These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides. Balestra D; Barbon E; Scalet D; Cavallari N; Perrone D; Zanibellato S; Bernardi F; Pinotti M Hum Mol Genet; 2015 Sep; 24(17):4809-16. PubMed ID: 26063760 [TBL] [Abstract][Full Text] [Related]
3. Analysis of novel missense ATR mutations reveals new splicing defects underlying Seckel syndrome. Llorens-Agost M; Luessing J; van Beneden A; Eykelenboom J; O'Reilly D; Bicknell LS; Reynolds JJ; van Koegelenberg M; Hurles ME; Brady AF; Jackson AP; Stewart GS; Lowndes NF Hum Mutat; 2018 Dec; 39(12):1847-1853. PubMed ID: 30199583 [TBL] [Abstract][Full Text] [Related]
4. Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model. Ichisima J; Suzuki NM; Samata B; Awaya T; Takahashi J; Hagiwara M; Nakahata T; Saito MK J Hum Genet; 2019 May; 64(5):445-458. PubMed ID: 30846821 [TBL] [Abstract][Full Text] [Related]
5. High-throughput analysis revealed mutations' diverging effects on Souček P; Réblová K; Kramárek M; Radová L; Grymová T; Hujová P; Kováčová T; Lexa M; Grodecká L; Freiberger T RNA Biol; 2019 Oct; 16(10):1364-1376. PubMed ID: 31213135 [TBL] [Abstract][Full Text] [Related]
6. Identification of the first ATRIP-deficient patient and novel mutations in ATR define a clinical spectrum for ATR-ATRIP Seckel Syndrome. Ogi T; Walker S; Stiff T; Hobson E; Limsirichaikul S; Carpenter G; Prescott K; Suri M; Byrd PJ; Matsuse M; Mitsutake N; Nakazawa Y; Vasudevan P; Barrow M; Stewart GS; Taylor AM; O'Driscoll M; Jeggo PA PLoS Genet; 2012; 8(11):e1002945. PubMed ID: 23144622 [TBL] [Abstract][Full Text] [Related]
7. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. O'Driscoll M; Ruiz-Perez VL; Woods CG; Jeggo PA; Goodship JA Nat Genet; 2003 Apr; 33(4):497-501. PubMed ID: 12640452 [TBL] [Abstract][Full Text] [Related]
8. Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides. Igreja S; Clarke LA; Botelho HM; Marques L; Amaral MD Hum Mutat; 2016 Feb; 37(2):209-15. PubMed ID: 26553470 [TBL] [Abstract][Full Text] [Related]
9. An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects. Fernandez Alanis E; Pinotti M; Dal Mas A; Balestra D; Cavallari N; Rogalska ME; Bernardi F; Pagani F Hum Mol Genet; 2012 Jun; 21(11):2389-98. PubMed ID: 22362925 [TBL] [Abstract][Full Text] [Related]
10. An Exon-Specific Small Nuclear U1 RNA (ExSpeU1) Improves Hepatic OTC Expression in a Splicing-Defective Balestra D; Ferrarese M; Lombardi S; Ziliotto N; Branchini A; Petersen N; Bosma P; Pinotti M; van de Graaf SFJ Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228018 [No Abstract] [Full Text] [Related]
11. In vitro correction of a pseudoexon-generating deep intronic mutation in LGMD2A by antisense oligonucleotides and modified small nuclear RNAs. Blázquez L; Aiastui A; Goicoechea M; Martins de Araujo M; Avril A; Beley C; García L; Valcárcel J; Fortes P; López de Munain A Hum Mutat; 2013 Oct; 34(10):1387-95. PubMed ID: 23864287 [TBL] [Abstract][Full Text] [Related]
12. Improvement of SMN2 pre-mRNA processing mediated by exon-specific U1 small nuclear RNA. Dal Mas A; Rogalska ME; Bussani E; Pagani F Am J Hum Genet; 2015 Jan; 96(1):93-103. PubMed ID: 25557785 [TBL] [Abstract][Full Text] [Related]
13. Intronic PAH gene mutations cause a splicing defect by a novel mechanism involving U1snRNP binding downstream of the 5' splice site. Martínez-Pizarro A; Dembic M; Pérez B; Andresen BS; Desviat LR PLoS Genet; 2018 Apr; 14(4):e1007360. PubMed ID: 29684050 [TBL] [Abstract][Full Text] [Related]
14. Disease-causing variants of the conserved +2T of 5' splice sites can be rescued by engineered U1snRNAs. Scalet D; Maestri I; Branchini A; Bernardi F; Pinotti M; Balestra D Hum Mutat; 2019 Jan; 40(1):48-52. PubMed ID: 30408273 [TBL] [Abstract][Full Text] [Related]
15. Antisense Oligonucleotides Modulating Activation of a Nonsense-Mediated RNA Decay Switch Exon in the ATM Gene. Kralovicova J; Moreno PM; Cross NC; Pêgo AP; Vorechovsky I Nucleic Acid Ther; 2016 Dec; 26(6):392-400. PubMed ID: 27658045 [TBL] [Abstract][Full Text] [Related]
16. Exon-Specific U1s Correct SPINK5 Exon 11 Skipping Caused by a Synonymous Substitution that Affects a Bifunctional Splicing Regulatory Element. Dal Mas A; Fortugno P; Donadon I; Levati L; Castiglia D; Pagani F Hum Mutat; 2015 May; 36(5):504-12. PubMed ID: 25665175 [TBL] [Abstract][Full Text] [Related]
17. Activation of a cryptic 5' splice site reverses the impact of pathogenic splice site mutations in the spinal muscular atrophy gene. Singh NN; Del Rio-Malewski JB; Luo D; Ottesen EW; Howell MD; Singh RN Nucleic Acids Res; 2017 Dec; 45(21):12214-12240. PubMed ID: 28981879 [TBL] [Abstract][Full Text] [Related]
18. An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A. Balestra D; Maestri I; Branchini A; Ferrarese M; Bernardi F; Pinotti M Front Genet; 2019; 10():974. PubMed ID: 31649737 [TBL] [Abstract][Full Text] [Related]
19. The prevalent deep intronic c. 639+919 G>A GLA mutation causes pseudoexon activation and Fabry disease by abolishing the binding of hnRNPA1 and hnRNP A2/B1 to a splicing silencer. Palhais B; Dembic M; Sabaratnam R; Nielsen KS; Doktor TK; Bruun GH; Andresen BS Mol Genet Metab; 2016 Nov; 119(3):258-269. PubMed ID: 27595546 [TBL] [Abstract][Full Text] [Related]
20. RNA Secondary Structure-Based Design of Antisense Peptide Nucleic Acids for Modulating Disease-Associated Aberrant Tau Pre-mRNA Alternative Splicing. Ong AAL; Tan J; Bhadra M; Dezanet C; Patil KM; Chong MS; Kierzek R; Decout JL; Roca X; Chen G Molecules; 2019 Aug; 24(16):. PubMed ID: 31434312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]